Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15657157 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 2;   Kidney Failure, Chronic;   Hyperlipidemia
Interventions: Drug: Extended release niacin;   Other: Placebo

Indicates status has not been verified in more than two years